How McKesson Beat Wall Street Estimates in Q4

McKesson (NYSE: MCK) wasn't immune to the impact of the novel coronavirus. Its shares plunged more than 30% at one point during the massive market sell-off in March fueled by the COVID-19 pandemic. However, McKesson has regained around half of its decline so far. And the stock could now gain even more upward momentum.

The healthcare giant announced its fiscal 2020 fourth-quarter and full-year results on Wednesday before the market opened. Here are the highlights from McKesson's Q4 update.

Image Source: Getty Images.